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a b s t r a c t
Objectives: To evaluate: (1) the in vitro antibacterial, cytotoxic and mechanical properties
of a resin-modified glass ionomer cement (RMGIC) containing different concentrations of
chlorhexidine (CHX) and (2) the in vivo microbiologic action of the best concentration of
CHX associated with the RMGIC applied on remaining dentine after indirect pulp treat-
ment (IPT).
Methods: For the in vitro studies, RMGIC was associated with 0.2, 0.5, 1.25 and 2.5% CHX.
Microbiologic evaluation consisted of an agar diffusion test on cariogenic bacteria for 24 h.
Odontoblast-like cell metabolism and morphology analyses measured the cytotoxic effects
of the RMGIC groups after 24 h. The same groups were submitted to compressive and
diametral tensile strength. The in vivo treatment consisted of IPT using an RMGIC associated
with the best CHX concentration. Clinical and microbiologic evaluations were performed
before and after 3 months.
Results: The use of 1.25% CHX significantly improved the antibacterial effects of the
evaluated RMGIC, without causing any detrimental effects to the odontoblast-like cells
and on the mechanical properties. This RMGIC and CHX combination completely eliminated
mutans streptococci after 3 months of IPT.
Conclusion: The RMGIC and 1.25% CHX mixture showed great biological and mechanical
behaviour and could be a good treatment against caries progression.
Clinical significance: The association of CHX with a liner RMGIC opens a new perspective for
arresting residual caries after IPT.
# 2012 Elsevier Ltd. 
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Partial caries removal approaches for dental caries manage-
ment have gained great importance in the last decade, since
scientific literature has suggested that only the softened
(infected) dentine should be removed from carious tissue.1
The remineralization capacity of affected dentine has also led
to the acceptance of partial caries removal as an effective
practice to avoid excessive excavation and the risk of pulp
exposure in deep cavities.2 This way, this procedure could
induce dentine repair, arrest of the carious process and
maintain pulp vitality.3,4
Even after removal of the infected layer and adequate
sealing, viable bacteria have been consistently found in the
remaining affected dentine after different periods of evalua-
tion, irrespective of the material applied on the residual
carious dentine.3–7 A therapeutic benefit was gained when
antimicrobial substances were used in association with a glass
ionomer cement to contribute to residual infection elimina-
tion, and thus, minimizing the risk of recurrent caries and
damage to the pulp.8
Among the different antimicrobial agents used to control
dental microorganisms, chlorhexidine has been considered as
one of the most effective and safe substances. It presents a
wide spectrum of activity against Gram positive bacteria,
especially mutans streptococci, Gram negative, aerobic and
facultative anaerobic bacteria, yeasts and fungi.9 Therefore,
chlorhexidine might be a promising substance in the
treatment of caries since its characteristics agree with of
the establishment of health and function of teeth. Studies
have suggested the incorporation of this agent into glass
ionomer cements to improve their inhibitory action on
residual microorganisms, contributing to the reduction of
secondary caries.10–14 Although the addition of chlorhexidine
into a glass ionomer cement must increase the antimicrobial
activity of the dental material, the presence of that substance
might produce toxicity to pulp cells when applied in deep
cavities, modify the physical characteristics of the cement or
both. Studies have demonstrated that high concentrations of
chlorhexidine cause damage to odontoblastic cells,15 or
jeopardize the basic properties of materials.13,14 For a secure
and adequate dental treatment, the concentration of the
antimicrobial agent to be used in association with dental
materials must be defined before its application. An in
vitro study demonstrated a slight caries-inhibiting effect of
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b Sigma–Aldrich (www.sigma-aldrich.com).compromising its physical characteristics8; however, no
studies have demonstrated if their combination can affect
odontoblast cells, an essential property to preserve pulpal
health. Furthermore, glass ionomer cements are used as liners
on affected dentine during partial caries removal procedures,
and the association of those liners materials and chlorhexi-
dine digluconate was not yet been studied. Therefore, this
present study determined the therapeutic concentration of
chlorhexidine digluconate that is necessary to produce
anticariogenic action without causing toxic effects on odon-
toblast-like cells while also causing no negative effects on the
mechanical properties of the restorative material when
incorporated into a resin-modified glass ionomer cement.
The best chlorhexidine/glass ionomer cement combination
was used on residual carious dentine after in vivo indirect pulp
treatment for a subsequent microbiological and clinical
evaluation. Four hypotheses were tested when adding
chlorhexidine digluconate to a resin-modified glass ionomer
cement (RMGIC): (1) the in vitro antibacterial effect of the
RMGIC/CHX mix is improved; (2) there is no cytotoxic effect on
the odontoblast-like cells; (3) the mechanical properties of the
RMGIC are not modified; and (4) the RMGIC mix reduces or
eliminates any residual bacteria from cavities after indirect
pulpal treatment.
2. Materials and methods
2.1. Dental materials
The liner resin modified glass ionomer cement (RMGIC)
chosen for the current study was GC Fuji Lining LC (FLLC –
Lot 0710021, GC Corporation, Tokyo, Japan). The composition
of this RGMIC is presented in Table 1. This material was
modified by adding 0.2%, 0.5%, 1.25%, and 2.5% chlorhexidine
digluconate (CHX – C9394 Sigma–Aldrich, Steinheim,
Germany) (w/w) to the liquid of the RMGIC while keeping
original powder/liquid ratio (1.4:1.0 g). Those concentrations
and the material preparation were determined based on the
results obtained from Tu¨rku¨n et al.14
2.2. In vitro evaluations
2.2.1. Microbial strains and growth media
Stock cultures of Streptococcus mutans (UA159), Lactobacillus
acidophilus (ATCC #IAL-523), Lactobacillus casei (ATCC #193) and
Actinomyces viscosus (T14V #IAL.5) from the Microbiology andrporation) and antimicrobial used in the study.
% Manufacturer Batch number
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sity of Campinas, Piracicaba, Sa˜o Paulo, Brazil were used in
this present study. For each experiment, cells were fresh
cultured from frozen stock on brain–heart infusion broth (BHI;
DIFCO Laboratories, Detroit, MI, USA) for 24 h at 37 8C in 10%
CO2 in an incubator. After confirming the viability and absence
of contamination by plating in a specific medium and Gram
techniques, cultures were again grown in BHI for 18–24 h at
37 8C and adjusted to a concentration of 1  108 cells/mL to
obtain an inoculum for subsequent testing.
2.2.2. Agar diffusion test15
In each sterilized Petri dish (20 mm  100 mm), a base layer
containing 15 mL of BHI agar mixed with 300 mL of each
inoculum was prepared. After solidification of the culture
medium, six wells measuring 5 mm in diameter were made in
each plate and completely filled with one of the experimental
control materials (RMGIC with chlorhexidine digluconate 0.2,
0.5, 1.25 and 2.5%) or the control material (RMGIC). All
materials were handled under aseptic conditions according
to the manufacturer’s instructions and inserted into wells
using a syringe (Centrix Inc., Shelton, USA). The cements were
light activated for 30 s using a halogen curing unit (Curing
Light XL3000, 3MESPE). The light intensity (410 mW/cm2) was
monitored by a radiometer (Optilux 500, Demetron Kerr,
Danbury, CT, USA). Ten microliters of aqueous 0.2% chlorhex-
idine digluconate was applied on sterile filter paper discs
(n = 6), also 5 mm in diameter, which acted as a control of the
experiment. The plates were kept for 2 h at room temperature
for the diffusion of the materials and then were incubated at
37 8C for 24 h. After this period, inhibition zones around the
materials were measured using a digital calliper.
2.2.3. Culture of MDPC-23 cells16
Immortalized cells of an odontoblast-like cell line (MDPC-23)
were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM;
Sigma Chemical Co., St. Louis, MO, USA) supplemented with
10% foetal bovine serum (Gibco, Grand Island, NY, USA), with
100 IU/mL penicillin, 100 mg/mL streptomycin and 2 mmol/L
glutamine (Gibco) in a humidified incubator with 5% CO2 and
95% air at 37 8C (Isotemp; Fisher Scientific, Pittsburgh, PA,
USA). MDPC-23 cells were sub-cultured every 3 days until an
adequate number of cells were obtained for the present study.
The cells were then seeded (30,000 cells/cm2) in sterile 24-well
plates (Costar Corp., Cambridge, MA, USA), which were
maintained in the humidified incubator with 5% CO2 and
95% air at 37 8C for 48 h.
2.2.4. Analysis of cell metabolism by MTT assay16
The RMGIC, without or with 0.2, 0.5, 1.25 and 2.5% of
chlorhexidine digluconate, was hand-mixed and applied into
stainless-steel moulds with cylindrical apertures. Vitrebond
(3MESPE) was used as a positive control, because it has a high
cytotoxic effect on odontoblast cells.16 Ten round-shaped
samples of each group (2 mm thick and 4 mm diameter) were
prepared, light-cured for 30 s and maintained for 1 h at 37 8C –
100% humidity. The specimens were then inserted separately
into sterile 24-well plates containing DMEM medium for 24 h.
After this period, 800 mL of extract of each well was applied to
previously cultured MDPC-23 cells for 24 h. Eight out of 10specimens were used for analysis of cell metabolism by the
cytochemical demonstration of succinic dehydrogenase (SDH)
activity, which is a measure of the mitochondrial respiration
of the cells, employing the methyl tetrazolium (MTT) assay.
For the MTT assay, the extracts were aspirated and replaced by
900 mL of DMEM plus 100 mL of MTT solution (5 mg/mL sterile
PBS; Sigma Chemical Co., St. Louis, MO, USA). The culture
media with the MTT solution were then aspirated and
replaced by 600 mL of acidified isopropanol solution (0.04 N
HCl) in each well to dissolve the formazan crystals resulting
from the cleavage of the MTT salt ring by the SDH enzyme
present in the mitochondria of viable cells. Three 100 mL
aliquots of each well were transferred to 96-well plates (Costar
Corp., Cambridge, MA, USA). Cell viability was evaluated by
spectrophotometry as being proportional to the absorbance
measured at the 570 nm wavelength with an ELISA microplate
reader (model 3550-UV, Bio-Rad Laboratories, Hercules, CA,
USA).
The values obtained from the 3 aliquots were averaged to
provide a single value for each well. The means were
calculated for the groups and transformed into percentages,
which represented the inhibitory effect of the mitochondrial
activity of the cells by the extracts. The negative control
(DMEM) was defined as having 100% cell metabolism.
2.2.5. Analysis of cell morphology by scanning electron
microscopy16
Cell morphology was examined by scanning electron micros-
copy (SEM) using two representative wells of each group. For
this purpose, sterile 12-mm-diameter cover glasses (Isotemp;
Fisher Scientific) were placed on the bottom of the wells of
sterile 24-well plates immediately before seeding of the MDPC-
23 cells. Then, the extracts were applied on the cells and the
plates were incubated for 24 h, as described before. Following
this incubation, the extracts were aspirated and the viable
cells that remained adhered to the glass substrate were fixed
in 1 mL of buffered 2.5% glutaraldehyde for 60 min. The cells
were then subjected to three 5-min rinses with 1 mL PBS, post-
fixed in 1% osmium tetroxide for 60 min and processed for
examination with a scanning electron microscope (JEOL-JMS-
T33A; JEOL, Tokyo, Japan).
2.2.6. Measurement of mechanical properties – compressive
and diametral tensile strength17,18
Four experimental groups (RMGIC-containing 0.2%, 0.5%,
1.25%, and 2.5% chlorhexidine digluconate) and one control
group (RMGIC) were established as described above for each
mechanical assay, both compressive and diametral tensile
strength (n = 50, 10 for each material group). Briefly, GC Fuji
Lining LC was mixed by agglutination of powder to liquid with
or without chlorhexidine and then the mixture was placed
with Centrix syringe (Centrix Inc., Shelton, USA) into cylindri-
cal moulds (4 mm high  2 mm diameter). The specimens
were then exposed to a light source (Curing Light XL3000,
3MESPE), with 410 mW/cm2 light intensity for 30 s. Afterwards,
the specimens were stored in distilled water for 24 h at 37 8C.
The specimens were submitted to compressive strength
testing in an Instron universal test machine (4411, Instron
Co., Canton, Mass, USA) at a crosshead speed of 1.0 mm/min
until failure occurred. Compressive strength values (kgf/cm2)
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area and converted into MPa. Diametral tensile strength was
carried out in an Instron universal test machine (4411, Instron
Co., Canton, Mass, USA) at 0.5 mm/min crosshead speed. The
strength values (kgf/cm2) were calculated using the equation:
DTS = 2F/3.14DT, where F was the failure load, D the diameter,
and T the height of the specimen. DTS values were converted
into MPa.
2.3. In vivo study
After approval by the Ethics Committee of the Piracicaba
Dental School – State University of Campinas (FOP-UNICAMP,
protocol 031/2008), sixteen primary molars were selected from
10 children of both genders, aged 4–9 years. A signed informed
consent was obtained from the legal guardians of the children.
Criteria for inclusion in the study were: (a) an active deep
carious lesion at the internal half of the dentine thickness of a
primary molar that had not been previously restored and that
involved the occlusal or occluso-proximal surface; (b) an
absence of signs of irreversible damage to the pulp, such as
spontaneous pain, a fistula, or tooth mobility; (c) the absence
of radiolucencies at the interradicular or periapical region or
thickening of the periodontal spaces, absence of internal and
external root resorption, absence of calcification of the pulp
tissue, as determined by radiographic examination; (d)
children presenting no systemic disease or those not using
medications.
2.3.1. Clinical procedures and dentine sampling7
Indirect pulp treatment was performed in two sessions by
the same investigator (ARCF), to standardize the clinical
procedures and the dentine collection procedures. At the
first session, after taking a bitewing radiograph using a
standardized positioner, anaesthesia was delivered and a
rubber dam applied to isolate the tooth. Pumice-slurry dental
prophylaxis and anti-sepsis of the operative area using 0.2%
chlorexidine digluconate was performed. Access to the
infected dentine was achieved using a high speed sterile
carbide bur (#245 – KG Sorensen, Barueri, Sa˜o Paulo, Brazil) toFig. 1 – Means and standard deviations of inhibition zones for 
concentrations of chlorhexidine digluconate (CHX) against S. m
obtained for these test groups differ statistically from the contr
Whitney tests ( p = 0.05).remove the undermined enamel, when necessary. After
removal of the superficial necrotic dentine using a spoon
excavator, a sterile round steel bur, compatible with the
cavity size, was used at low speed to clean all carious tissue
from the enamel-dentine junction and lateral walls, leaving
a layer of soft dentine on the cavity floor to avoid pulp
exposure. After washing and air-drying the cavities to
remove debris, an initial collection (baseline) of carious
dentine was sampled from the mesial portion of the cavity
floor and inserted into 5 mL of 0.9% NaCl. In order to obtain
similar amounts of carious tissue from different collections,
a standardized cavity was prepared in the active extremity of
an amalgam plugger using a spherical bur at high speed. This
cavity was completely filled with the dentine samples
(approximately 0.6 mg) removed from each tooth using a
sterile spoon excavator. Subsequently, the pulpal wall was
entirely covered with one of the randomly selected liner
materials: (1) liner RMGIC (n = 8) (FL; Lot 0710021, GC
Corporation, Tokyo, Japan) containing 1.25% chlorhexidine
digluconate (CHX; C9394 Sigma–Aldrich, Steinheim,
Germany) or (2) Fuji Lining LC as a control group (n = 8).
The experimental liner RMGIC was modified by adding CHX
to the liquid of the GC Fuji Lining LC while keeping the
original powder/liquid ratio (1.4:1.0 g), as described in
Section 2.1. The CHX concentration was chosen based in
the previous results obtained in this study. The materials
were handled according to the manufactures’ instructions.
The liner RMGIC was light activated for 30 s using a halogen
curing unit (Curing Light XL3000, 3MESPE, St. Paul, MN, USA)
and the light intensity (410 mW/cm2) was monitored using a
radiometer (Optilux 500, Demetron Kerr, Danbury, CT, USA).
The cavities were then temporarily restored using a
conventional GIC (Ketac Molar, 3 M ESPE, Seefeld, Bavaria,
GE). Within 3 months after the initial treatment, the teeth
were submitted to clinical and radiographic examination to
determine signs and symptoms of pulp vitality. Next, under
the same initial conditions of anaesthesia and rubber dam
placement, the teeth were reopened. The restorative and
liner materials were carefully and completely removed and a
new dentine sample was collected, as previously described.Fuji Lining LC (FLLC) associated or not to different
utans, L. acidophilus, L. casei, and A. viscosus. *Values
ol group (FLLC), according to Kruskal Wallis and Mann–
Fig. 2 – Box–Whisker plot (minimum [lower quartile–
median–upper quartile] maximum) of the cell metabolism
(MTT assay) results for each group. *Mean W standard
deviation. The vertical line in the box is the median.
**Groups identified with the same letter do not differ
statistically (Mann–Whitney; p > 0.05).
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was removed, and the teeth were then restored with a light-
cured composite resin (Opallis, FGM, Joinvile, SC, Brazil)
using a bonding system, Scotchbond Multi-Purpose (3M
ESPE, St. Paul, MN, USA), after a new placement of the initial
liner material.
2.3.2. Clinical evaluation criteria
Before all dentine collections, the dental cavities were
copiously washed and carefully air dried, and the colour,
consistency and humidity of the carious dentine were blindly
evaluated by a second investigator, based on the following
criteria7: dentine consistency: 0 = hard (similar to normal
dentine); 1 = leathery (dentine spoon removes carious tissue
when forced); 2 = soft (tissue easily removed by a dentine
spoon); dentine colour: 0 = yellow; 1 = light brown; 2 = dark
brown; dentine humidity: 0 = dry; 1 = humid
2.3.3. Microbiological procedures7
Dentine samples immersed in 5 mL of 0.9% NaCl were
homogenized in a tube agitator (Vortex, Phoenix AT 56,
Munising, Mich., USA) for 1 min. Six decimal dilutions (101–
106) were performed after homogenization. Subsequently,
25 ml aliquots of the dilutions were cultivated in triplicate on a
surface containing Bacitracin 0.2 UI/mL Mitis Salivarius – MSB
agar for isolation of mutans streptococci (MS). All plates were
incubated in a microaerophilic environment at 37 8C for 48 h.
After incubation, the total number of colony-forming units per
millilitre (CFU/mL) was counted from a representative area of
each agar plate, yielding 50–300 colonies using a stereoscopic
microscope.
2.4. Statistical analysis
Data from the antibacterial and cytotoxic effects were
submitted to Kruskal Wallis and Mann–Whitney tests, and
the data from the evaluation of the mechanical properties
were submitted to one-way ANOVA and Tukey tests ( p < 0.05).
The Wilcoxon’s non-parametric test was used to compare
the differences in consistency, colour, and humidity of the
dentine, before and after the indirect pulp treatment. The
counts of MS were compared between the samples collected at
baseline and after 3 months within each material group using
the same test. Medians and ranges of bacterial counts were
expressed as (log(CFU + 1)). The constant 1 was added to the
CFU count, since many samples showed zero CFUs after the
experimental period. Complementary Mann–Whitney tests
were applied to identify differences among the materials. All
statistical tests were considered at a 5% level of significance.
3. Results
3.1. In vitro evaluations
3.1.1. Antibacterial activity
The mean values of the inhibition zones for each material
are shown in Fig. 1. The concentrations of 0.2 and 0.5%
chlorhexidine digluconate did not have an effect on the
antibacterial activity of RMGIC. The incorporation of 1.25 and2.5% chlorhexidine digluconate significantly improved the
inhibitory activity of the cement on all of the bacteria tested,
except for 1.25% chlorhexidine digluconate against L. acidophi-
lus. When comparing these two groups, there was a statisti-
cally significant difference between them for S. mutans and L.
acidophilus.
3.1.2. Toxicity on odontoblast-like cells
Fig. 2 shows the cell metabolism (SDH activity) following
application of the culture medium with or without the
experimental materials. The 2.5% chlorhexidine digluconate
in association with RMGIC caused significant reduction in the
metabolism of MDPC-23 cells when compared to the controls
(RMGIC and DMEM). Vitrebond showed the highest cytotoxic
effects, decreasing the metabolic activity by 93%. RMGIC
associated with 0.2 and 0.5 CHX increased significantly the
SDH activity (14.03% and 12.6%, respectively) which statisti-
cally differed from the control group (DMEM), showing that
low concentrations of chlorhexidine digluconate could stimu-
late cell metabolism. There was no difference between 1.25%
chlorhexidine digluconate and the RMGIC and DMEM groups.
SEM images indicated that chlorhexidine digluconate con-
centrations of up to 1.25% when incorporated into RMGIC did
not affect cell morphology: numerous MDPC-23 cells, near
confluence, remained adhered to the glass substrate and
exhibited an elongated morphology with several thin cyto-
plasmatic prolongations originating from their membrane.
However, RMGIC containing chlorhexidine digluconate at a
2.5% concentration slightly altered the morphology of MDPC-
23 cells. A small number of cells were observed for Vitrebond
(Fig. 3).
3.1.3. Measurements of mechanical tests
The means and standard deviations of the values obtained for
mechanical testing are shown in Figs. 4 and 5. The 2.5%
Fig. 3 – MDPC-23 cells adhered to the glass substrate after exposure to extracts of (A) Fuji Lining LC (FLLC) containing 0.2%
chlorhexidine digluconate; (B) FLLC containing 0.5% chlorhexidine digluconate; (C) FLLC containing 1.25% chlorhexidine
digluconate; (D) FLLC containing 2.5% chlorhexidine digluconate; (E) control group – FLLC without chlorhexidine
digluconate; and (F) Vitrebond (SEM original magnification 1000T).
Fig. 4 – Mean (bars) and standard deviation (lines) of
compressive strength values obtained for the different
groups. Different letters indicate statistically different
groups (ANOVA; p < 0.05).
Fig. 5 – Mean (bars) and standard deviation (lines) of
diametral tensile strength values obtained for the different
groups. Groups identified with the same letter do not differ
statistically (ANOVA; p > 0.05).
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Table 2 – Median and range (minimum–maximum) of clinical scores and SM counts (log(UFC + 1)) according to the collect
period and experimental materials.
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* For each material and collect, median (range) followed by: Same lowercase letters in the rows are not statistically different, according to
Wilcoxon and Mann–Whitney test ( p > 0.05). Same uppercase letters in columns are not statistically different, according to Wilcoxon and
Mann–Whitney test ( p > 0.05).
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pressive strength when compared to the control. No signifi-
cant differences were observed among the groups for
diametral tensile test ( p < 0.05), demonstrating that the
incorporation of chlorhexidine digluconate into RMGIC at up
to 2.5% concentrations did not modify this mechanical
property of the liner material.
3.2. In vivo investigation
Three teeth were excluded from this evaluation due to the loss
of the restoration (1 from the control group and 2 from the CHX
group). The final sample consisted of 13 teeth (control = 7 and
CHX = 6) from 10 patients. Table 2 shows the in vivo clinical
and microbiological results. None of the patients experienced
any sensitivity or discomfort and no clinical or radiographic
signs of pulp or periapical alterations were noted during the
trial period. None of the teeth presented pulp exposures
during the reopening of the cavity. The comparison between
the bacterial counts before and after sealing the cavity showed
no significant reduction for the control group ( p > 0.05) and
complete elimination of SM (UFC = 0) from the cavities of the
experimental group.
4. Discussion
Glass ionomer cements (GIC) are widely used in dentistry for
its advantages of non-shrinking setting reaction, combined
with adhesion to tooth tissue and fluoride release. However,
conventional GIC (CGIC) is quite a brittle material and its
mechanical properties are limited. Because of this, resin-
modified glass ionomer cements (RMGICs) were introduced to
provide a material with improved mechanical properties and
the light cure facility.19 Besides the components of the CGIC,
the RMGICs contain usually hydroxyl-ethylmethacrylate
(HEMA) and polymerization initiators. The good biocompati-
bility of the CGIC attributed to minimal setting exothermic,
rapid acid neutralization and slow release of beneficial ions
was impaired by the incorporation of the monomers, such as
HEMA. The liner RMGIC more commonly used by dentists is
Vitrebond, but its high percentage of HEMA release has
showed to be highly cytotoxic.20 In this study, the RMGIC Fuji
Lining LC was chosen for its good sealing capacity along thecavity wall as well as the reduced cytotoxicity. Aranha et al.21
evaluated SDH activity after exposition to some RMGICs and
verified that Fuji Lining LC provided minimal reduction in the
cellular metabolism (9.3%) when compared to Vitrebond
(80.7%). Palmer et al.22 compared the percentage HEMA release
from restorative and liner RMGIC. After 24 h of maturation,
light-activated Vitrebond specimens released 4.95% of HEMA
compared to 0.59% from Fuji Lining LC. When these cements
were not light-cured, the percentage of HEMA release was 4.01
for Fuji Lining LC and 59.78 for Vitrebond.
The efficacy of chlorhexidine has been proven against oral
pathogens.9 Therefore, different salts of chlorhexidine, mainly
digluconate and diacetate, have been added to GICs for
improving their antimicrobial efficacy. The incorporation of
this agent in dental materials could reduce or eliminate
residual bacteria after caries removal procedures or until
prevent secondary caries around the restoration. In this
current study, the addition of 1.25% and 2.5% chlorhexidine
digluconate to a liner RMGIC substantially increased its
inhibitory activity against the tested oral bacteria when
compared with RMGIC alone. Similar results were found in
other studies, using digluconate11,12,14 or other chlorhexidine
salts.8,11,13,14,23 Among the microorganisms tested, L. acidophi-
lus was the most resistant microorganism to chlorhexidine
digluconate-containing RMGI. According to Botelho23 the
addition of chlorhexidine to glass ionomer cement is less
effective against that cariogenic bacteria than the addition of
cetylpyridinium chloride and benzalkonium chloride. Not-
withstanding, a chlorhexidine added to a glass ionomer
cement has a significant residual release effect for some
weeks,13 which could inhibit remaining microorganisms,
including L. acidophilus. Tu¨rku¨n et al.14 evaluated the in vitro
long-term antimicrobial effect of the incorporation of chlor-
hexidine in a CGIC and observed inhibitory halos against both
S. mutans and L. acidophilus after 30–40 days of the initial
cement application on agar plates.
Some studies have evaluated the release of chlorhexidine
from glass ionomer cements using high performance liquid
chromatography (HPLC) analysis and compared the relation-
ship between the percentage of CHX released and its
antibacterial effects. Some of the studies related that CHX
released from GICs and consequent inhibitory activity against
pathogens was dependent upon the concentration of that
antimicrobial11,23 while others showed no dose-response
j o u r n a l o f d e n t i s t r y 4 1 ( 2 0 1 3 ) 1 5 5 – 1 6 3162effects,8,24 showing conflicting results. Although in this
current study was not possible to measure the percentage
of CHX released by HPLC analysis, the antibacterial effect was
concentration-dependent since 1.25% and 2.5% concentra-
tions produced better results. These present findings are in
agreement with Ribeiro and Ericson11 and Botelho.23 In both
studies, the antibacterial-GIC combination specimens showed
significant inhibition which increased with the CHX concen-
trations. Characteristics such as viscosity and hardness of
glass ionomer cements could determine the amounts of
antimicrobials released.8
When maintaining the original ratio of power/liquid, the
addition of any substance could affect important character-
istics of glass ionomer cement. Antimicrobials could enhance
the cytotoxic effect of a dental material while interfering in its
mechanical properties. Although chlorhexidine digluconate is
a potential antimicrobial with many desirable biological
characteristics, such as inhibition of dentine metalloprotei-
nases,25 it may cause an immediate hypersensitivity and other
unwanted responses, including inhibiting protein synthesis
and mitochondrial activity.25,26 For those reasons, both
quantity and oral administration of the chlorhexidine diglu-
conate must be controlled. In relation to the toxicity of the
chlorhexidine substance on culture cells, studies in the
literature evaluated only the cytotoxicity of that antimicrobial
agent applied directly on cells, not in association with dental
materials. Lessa et al.27 evaluated the cytotoxicity of 0.06, 0.12,
0.2, 1 and 2% chlorhexidine digluconate on odontoblast-like
cells for 60 s to 24 h and observed that the antimicrobial had a
dose-time dependent toxic effect on MDPC-cells. The higher
the concentration of chlorhexidine digluconate and the longer
its contact time with odontoblast cells, the more intense the
cytotoxic effect of that chemical agent. In the present study,
extracts obtained after incubation of RMGIC specimens
associated with 0.2–1.25% of chlorhexidine digluconate for
24 h did not increase the toxicity on odontoblastic lineage
cells. However, the 2.5% chlorhexidine digluconate concen-
tration significantly reduced cell metabolism and changed the
cell morphology.
The idea of incorporating chlorhexidine digluconate into
dental materials used for filling or lining, such as glass
ionomer cement, is based on the improvement of their
antimicrobial activity. However, the addition of that antimi-
crobial substance to a glass ionomer cement can affect the
mechanical properties of that cement.8,13,28 Therefore, the
particular antimicrobial agent and its quantity are important
aspects to determine if the characteristics of the dental
material could be affected. In this current study, the inhibitory
action of RMGIC against all tested strains was improved by the
presence of chlorhexidine digluconate with no negative
effects to the mechanical properties of the cement, except
the 2.5% chlorhexidine digluconate concentration for com-
pressive strength test. These current results are in agreement
with Takahashi et al.8 who observed that 2% or greater
chlorhexidine diacetate significantly decreased the compres-
sive strength and the bond strength to dentine of conventional
glass ionomer cement. Those authors suggested that the
decrease in mechanical properties could be attributed to slight
modifications in the powder/liquid ratios by adding the
antimicrobial agent. In the present study, 2.5% chlorhexidinedigluconate affected two important properties of glass
ionomer cement: the cytotoxicity on odontoblast-like cells
and compressive strength of the cement. Alternatively,
chlorhexidine digluconate in a concentration of 1.25% could
be the ideal and safe concentration in a RMGIC used as a liner
in deep cavities. Based on the current in vitro results, an in vivo
study was conducted with FLLC and 1.25% CHX. This
combination completely eliminated mutans streptococci from
dentine samples after 3 months of clinical treatment.
Glass ionomer cements have been successfully used in
procedures involving partial caries removal, including indirect
pulp treatment, stepwise excavation and atraumatic restor-
ative treatment (ART).2–7 This is the first study evaluating both
in vivo and in vitro properties of a liner RMGIC containing
chlorhexidine digluconate as an alternative material for
eliminating residual bacteria after indirect pulp treatment.
A pilot study conducted by Frencken et al.10 showed lower
microorganism counts in chlorhexidine-containing glass
ionomers cements than in conventional GIC for both affected
and infected dentine over a 7-day period after ART procedures.
In a in situ study, the authors investigated the antibiofilm
effects of conventional GIC (CGIC) and RMGIC containing 2%
chlorhexidine diacetate. GIC and RMGIC specimens were
bonded to buccal surface of the molars of volunteers and left
untouched for 4 and 24 h. The bacterial viability was analyzed
by confocal laser scanning microscopy that revealed signifi-
cantly lower microorganism counting to CHX-containing
specimens compared to CGIC/RMGIC.29
5. Conclusion
The findings of this present study demonstrated that the use of
chlorhexidine digluconate in combination with RMGIC max-
imizes the antimicrobial activity of this cement. There is usually
no antimicrobial added to dental materials; however, the
combination of an antimicrobial with a glass ionomer cement
can provide better protection against cariogenic bacteria and
should avoid caries progression. Therefore, the current authors
propose that chlorhexidine digluconate is a potential candidate
as a therapeutic agent in caries management, especially in
partial caries removal procedures, and could be further
developed as a constituent for dental materials.
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